While the Chicago metropolitan area is not a major life sciences hub, a recent Cushman & Wakefield report predicts the Chicago market should be a growth spot in the coming years. Chicago Biomedical ...

Amgen Inc . (NASDAQ:AMGN), a leading biotechnology company with a market capitalization of $151.3 billion, is navigating a critical juncture in its growth trajectory as it advances its product ...

Stay updated on biotech layoffs in 2025! Each week, we track and analyze industry layoffs, their causes, and their impact.

Seventy-eight years ago, scientists created a unique sort of timepiece — named the Doomsday Clock — as a symbolic attempt to ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

A Bay Area biotech firm is laying off 75% of its staff following a flopped clinical trial. Allakos, based in San Carlos, ...

BioMed Realty, one of the biggest labspace owners in the Boston area, recently acquired 215 First St., 150 Second St. and 11 ...

Last year was a surprisingly big one for legal decisions impacting the biotechnology transactions and licensing space. Given that most biotech ...

Costly biomanufacturing sterilization process are impeding food-tech companies from scaling up — a problem Biosphere is ...

We recently compiled a list of the 12 Best Fundamental Stocks to Buy Now. In this article, we are going to take a look at ...

In less than 36 hours between the evening of Jan. 12 and the morning of Jan. 14, three local life science companies raised a ...

Right now, we actually have no plans to move forward; it’s ready to go if we decide,” company spokeswoman said.